Wenger Vieli Ltd is well-equipped to assist with mandates concerning the de-listing of reimbursed products, M&A, and product liability claims. Frank Scherrer leads the team with his longstanding expertise in establishment licences, marketing authorisations, and data protection issues. Marcel Boller is a key contact for pharma companies and pharmacies seeking advice on data exclusivity issues and joint ventures.
Legal 500 Editorial commentary
Work highlights
- Advising a global pharmaceutical company in relation to the introduction by the regulator of turnover based rebates.
- Represented a pharmaceutical company in appeal proceedings regarding the deletion of one of its products from the list of reimbursed products.
- Advised IK Partners on the EUR 370m sale of Klingel medical metal group to Elos Medtech.
Practice head
The lawyer(s) leading their teams.
Frank Scherrer